The Dark Side of the Tongue: The Stomatology Point of View on Oral Hyperpigmentation

Rui Seixas; Natacha Ribeiro; Carlos Matos

doi:10.20344/amp.19041

The Dark Side of the Tongue: The Stomatology Point of View on Oral Hyperpigmentation

Authors

Rui Seixas Serviço de Estomatologia. Hospital São Bernardo. Centro Hospitalar de Setúbal. Setúbal.; Instituto Superior de Educaçã o e Ciências. Lisboa.
Natacha Ribeiro Serviço de Estomatologia. Hospital São Bernardo. Centro Hospitalar de Setúbal. Setúbal.
Carlos Matos Serviço de Estomatologia. Hospital São Bernardo. Centro Hospitalar de Setúbal. Setúbal.

DOI:

https://doi.org/10.20344/amp.19041

Keywords:

oral hyperpigmentation, oral lesions, stomatology, temozolomide

Abstract

N/a.

Downloads

Download data is not yet available.

References

Gil LM, Marques J, Salgado D. Tongue hyperpigmentation associated with temozolomide as a single agent: case report. Acta Med Port. 2022;35:672-4.

Donnell CC, Walton RL, Carrozzo M. The blue palate — a case series of imatinib-related oral pigmentation and literature review. Oral Surg Oral Med Oral Pathol Oral Radiol. 2021;131:49-61.

Binmadi NO, Bawazir M, Alhindi N, Mawardi H, Mansour G, Alhamed S, et al. Medication-induced oral hyperpigmentation: a systematic review. Patient Prefer Adherence. 2020;14:1961-8.

Algahtani H, Marghalani S, Satti M, Shirah B. Levetiracetam-induced skin hyperpigmentation: an extremely rare undesirable side effect. J Epilepsy Res. 2017;7:106–8.

Nayak V, Kini R, Rao P, Bhandarkar G, Kashyap R, Shetty U, et al. Antiepileptic drug induced pigmentation of oral mucosa - a case report and review. J Drug Discov Develop and Deliv. 2017;4:3.

Downloads

Published

2022-10-21

How to Cite

Seixas R, Ribeiro N, Matos C. The Dark Side of the Tongue: The Stomatology Point of View on Oral Hyperpigmentation. Acta Med Port [Internet]. 2022 Oct. 21 [cited 2024 Nov. 22];35(12):924-. Available from: https://actamedicaportuguesa.com/revista/index.php/amp/article/view/19041

Download Citation

Issue

Vol. 35 No. 12 (2022): Dezembro

Section

Letters to the Editor

License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

All the articles published in the AMP are open access and comply with the requirements of funding agencies or academic institutions. The AMP is governed by the terms of the Creative Commons ‘Attribution – Non-Commercial Use - (CC-BY-NC)’ license, regarding the use by third parties.

It is the author’s responsibility to obtain approval for the reproduction of figures, tables, etc. from other publications.

Upon acceptance of an article for publication, the authors will be asked to complete the ICMJE “Copyright Liability and Copyright Sharing Statement “(http://www.actamedicaportuguesa.com/info/AMP-NormasPublicacao.pdf) and the “Declaration of Potential Conflicts of Interest” (http:// www.icmje.org/conflicts-of-interest). An e-mail will be sent to the corresponding author to acknowledge receipt of the manuscript.

After publication, the authors are authorised to make their articles available in repositories of their institutions of origin, as long as they always mention where they were published and according to the Creative Commons license.